These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32289333)

  • 1. Models of dystonia: an update.
    Imbriani P; Ponterio G; Tassone A; Sciamanna G; El Atiallah I; Bonsi P; Pisani A
    J Neurosci Methods; 2020 Jun; 339():108728. PubMed ID: 32289333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular and cell biology of dystonia: Focus on torsinA.
    Gonzalez-Alegre P
    Neurobiol Dis; 2019 Jul; 127():233-241. PubMed ID: 30877032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity, genetics and epigenetics in dystonia: An update.
    Sciamanna G; El Atiallah I; Montanari M; Pisani A
    Handb Clin Neurol; 2022; 184():199-206. PubMed ID: 35034734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
    Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
    Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensorimotor tests unmask a phenotype in the DYT1 knock-in mouse model of dystonia.
    Richter F; Gerstenberger J; Bauer A; Liang CC; Richter A
    Behav Brain Res; 2017 Jan; 317():536-541. PubMed ID: 27769743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia.
    Eskow Jaunarajs KL; Bonsi P; Chesselet MF; Standaert DG; Pisani A
    Prog Neurobiol; 2015 Apr; 127-128():91-107. PubMed ID: 25697043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.
    Beauvais G; Bode NM; Watson JL; Wen H; Glenn KA; Kawano H; Harata NC; Ehrlich ME; Gonzalez-Alegre P
    J Neurosci; 2016 Oct; 36(40):10245-10256. PubMed ID: 27707963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
    Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
    Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of rare TOR1A variant found in sporadic focal dystonia impairs domains affected in DYT1 dystonia patients and animal models.
    Bhagat SL; Qiu S; Caffall ZF; Wan Y; Pan Y; Rodriguiz RM; Wetsel WC; Badea A; Hochgeschwender U; Calakos N
    Neurobiol Dis; 2016 Sep; 93():137-45. PubMed ID: 27168150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.
    Eskow Jaunarajs KL; Scarduzio M; Ehrlich ME; McMahon LL; Standaert DG
    J Neurosci; 2019 Sep; 39(36):7195-7205. PubMed ID: 31320448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.
    Ponterio G; Tassone A; Sciamanna G; Vanni V; Meringolo M; Santoro M; Mercuri NB; Bonsi P; Pisani A
    Mov Disord; 2018 Feb; 33(2):310-320. PubMed ID: 29150865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia.
    Walker RH; Brin MF; Sandu D; Good PF; Shashidharan P
    Neurology; 2002 Jan; 58(1):120-4. PubMed ID: 11781416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
    Gonzalez-Alegre P; Paulson HL
    J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation.
    Kakazu Y; Koh JY; Ho KW; Gonzalez-Alegre P; Harata NC
    Synapse; 2012 May; 66(5):453-64. PubMed ID: 22213465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report.
    Gajos A; Piaskowski S; Sławek J; Ochudło S; Opala G; Łobińska A; Honczarenko K; Budrewicz S; Koszewicz M; Pełszyńska B; Liberski PP; Bogucki A
    Neurol Neurochir Pol; 2007; 41(6):487-94. PubMed ID: 18224570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of torsinA in dystonia.
    Granata A; Warner TT
    Eur J Neurol; 2010 Jul; 17 Suppl 1():81-7. PubMed ID: 20590813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia.
    Martella G; Maltese M; Nisticò R; Schirinzi T; Madeo G; Sciamanna G; Ponterio G; Tassone A; Mandolesi G; Vanni V; Pignatelli M; Bonsi P; Pisani A
    Neurobiol Dis; 2014 May; 65():124-32. PubMed ID: 24503369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers.
    Duane DD
    Neurology; 2005 May; 64(10):1821-2; author reply 1821-2. PubMed ID: 15911830
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: Dopaminergic dysfunction in DYT1 dystonia.
    Wichmann T
    Exp Neurol; 2008 Aug; 212(2):242-6. PubMed ID: 18513716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
    Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y
    Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.